Professional Documents
Culture Documents
ValueInvesting - Io - Financials & Models Template
ValueInvesting - Io - Financials & Models Template
ValueInvesting - Io - Financials & Models Template
Operating country:
Industry:
Low
Long-term growth rate 3.0%
United States
Technology Hardware, Storage & Peripherals
Explanation
If 'Yes', we adjust yellow cells' values when the ticker changes
millions
Used in sensitivity analysis
Used in sensitivity analysis
High
5.0%
Choose 'Yes' (after starting the add-in once) if you just need financial data to bu
models. Please build your models in new sheets, DO NOT modify existing shee
ge & Peripherals
Income Statement
His
(USD in millions)
Sep-2017
Revenue 229,234
Cost of goods sold (141,048)
Gross profits 88,186
Selling, G&A expenses (15,261)
Research & Development (11,581)
Net other income/(expense) (133)
32 32 21 26
125 104 91 94
9 9 9 11
- - - -
Historical
Sep-2018 Sep-2019 Sep-2020 Sep-2021
265,595 260,174 274,515 365,817
(163,756) (161,782) (169,559) (212,981)
101,839 98,392 104,956 152,836
(16,705) (18,245) (19,916) (21,973)
(14,236) (16,217) (18,752) (21,914)
(441) 422 (87) 60
fill
formula
fill
formula
fill
formula
Discounted Cash Flow 5Y Growth Exit
Range Selected
WACC / Discount Rate 6.4% - 8.6% 7.51%
Long-term Growth Rate 3% - 5% 4.00%
Fair Price 120.39 - 474.44 190.23
Upside -12.5% - 244.8% 38.3%
Upside
38.3%
Stock Price
137.59 USD
Fair Price
190.23 USD
0
Revenue & Expenses Forecast
Projecti
(USD in millions)
Sep-2021 Sep-2022 Sep-2023
Other incomes/expenses 60 62 65
% of Revenue 0.0% 0.0% 0.0%
70 74 77
0.0% 0.0% 0.0%
Days receivables 27
Trade receivables 26,278
Days payables 96
Trade payables (54,763)
Days inventory 10
Inventory 6,580
(USD in millions)
Capex
% of Revenue
5y Avg
Capex 10,931
% of Revenue 4.0%
Depreciation & Amortization Schedule
(USD in millions)
For CAPEX in
2018
2019
2020
2021
2022
2023
2024
2025
2026
27 25 26 26
27,630 27,010 30,165 32,003
96 94 95 95
(57,123) (57,212) (60,517) (63,397)
10 10 10 10
5,784 6,057 6,597 6,679
Projections
Sep-2022 Sep-2023 Sep-2024 Sep-2025
Historical
Sep-2017 Sep-2018 Sep-2019 Sep-2020
2,663
2,099 2,099
1,462 1,462 1,462
2,217 2,217 2,217 2,217
3,058 3,058 3,058 3,058
3,213 3,213 3,213
3,435 3,435
3,662
25
32,816
94
(64,101)
10
6,842
(24,443)
272
Sep-2026
18,986
4.0%
Sep-2021
11,085
3.0%
2026
3,058
3,213
3,435
3,662
3,797
17,166
2,663
4,198
4,385
8,868
15,292
16,067
17,176
18,308
18,986
Weighted Average Cost of Capital
Detailed calculations
Tax rate
Cost of debt
Method 1 (effective interest rate)
(USD in millions)
Interest expense
Total debt
Effective interest rate
Cost of debt 1
(average effective interest rates)
TTM EBIT
(/) TTM Interest expense
TTM Interest coverage ratio
Cost of debt 2
Source
https://tradingeconomics.com/bonds
http://pages.stern.nyu.edu/~adamodar/New_Home_Page
Company History
Sep-2017 Sep-2018 Sep-2019
24.56% 16.28% 15.94%
15.34%
16.08%
15.94%
Historical
Sep-2017 Sep-2018 Sep-2019
2,092 3,022 3,423
115,680 114,483 108,047
2.61% 2.99%
2.69%
118,991
2,766
43.02
0.69% Source
AAA
3.25%
com/bonds
u/~adamodar/New_Home_Page/datafile/ctryprem.html
y History
Sep-2020 Sep-2021
14.43% 13.30%
orical
Sep-2020 Sep-2021
3,002 2,687
113,097 125,567
2.78% 2.38%
http://www.stern.nyu.edu/~adamodar/pc/ratings.xls
Enterprise/Equity Value Calculations
(USD in millions)
Sensitivity Analysis
WACC 8.64%
Long-term growth rate 3.0%
Terminal value
WACC 6.38%
Long-term growth rate 5.0%
Terminal value
Projections
6M/FY22 FY23 FY24 FY25
47,327 95,604 97,170 100,697
4.00 4.50
103,201 2,720,354
FY26 Terminal
2,323,944
98,983 1,600,641
9,656,409
107,647 7,309,427
P/E
Range Selected
Trailing P/E multiples 9.6x - 16.5x 12.25x
Forward P/E multiples 14.64x - 16.98x 16.55x
Fair Price 60.46 - 103.92 89.1
Upside -56.1% - -24.5% -35.2%
Industry median
(*) Profit after tax
Equity value
EV / EBITDA
Range Selected
Trailing EV/EBITDA multiples 4.6x - 9.34x 5.35x
Forward EV/EBITDA multiples 3.32x - 11.52x 7.6x
Fair Price 20.76 - 86.05 46.1
Upside -84.9% - -37.5% -66.5%
Industry median
(*) EBITDA
Enterprise value
(-) Net debt
Equity value
Stock Price
137.59 USD
Fair Price
89.10 USD
Sensitivity Analysis
12.25x 16.55x
101,935 98,828
1,248,704 1,635,601
16,185 16,185
77.15 101.06
77.15 101.06
Upside
-66.5%
Stock Price
137.59 USD
Fair Price
46.11 USD
Sensitivity Analysis
Trailing Forward
EV/EBITDA EV/EBITDA
5.35x 7.6x
130,246 128,867
696,816 979,390
91,883 91,883
604,933 887,507
16,185 16,185
37.38 54.83
37.38 54.83
nalysis
Low High
Trailing P/E Forward P/E Trailing P/E Forward P/E
Range Selected
WACC / Discount Rate 6.4% - 8.6% 7.51%
Normalized Earnings 66,572 66,572
Fair Price 41.94 - 58.76 50.3
Upside -69.5% - -57.3% -63.4%
(USD in millions)
Sep-2017
Revenue 229,234
Sustainable revenue 300,169
Low High
Normalized Earnings 66,572 66,572
(/) WACC 8.64% 6.38%
Enterprise Value 770,613 1,042,885
(-) Net debt 91,883 91,883
Equity Value 678,730 951,002
(/) Outstanding shares 16,185 16,185
Fair price 41.94 58.76
Fair price (USD) 41.94 58.76
Upside
-63.4%
Stock Price
137.59 USD
Fair Price
50.35 USD
Historical
Range
Long-term Growth Rate 3% - 5%
Cost of Equity 6.6% - 8.9%
Fair Price 74.34 - 362.60
Upside -46% - 163.5%
Range
Long-term Growth Rate 3% - 5%
Cost of Equity 6.6% - 8.9%
Fair Price 96.40 - 361.99
Upside -29.9% - 163.1%
Current payout ratio 14.45%
Stable payout ratio 90.00%
(USD in millions)
6M/FY22
Sensitivity Analysis
6M/FY22
Cost of equity 8.93%
Long-term growth rate 3.0%
Present value of dividends 6,991
Low
Equity value 1,560,318
Fair price 96.40
Fair price (USD) 96.40
Cost of equity 6.56%
Long-term growth rate 5.0%
Present value of dividends 7,030
High
Equity value 5,858,912
Fair price 361.99
Fair price (USD) 361.99
Upside
58.8%
High
90%
101,935
91,742
6.56%
5.00%
5,868,787
16,185
362.60
362.60
Upside
10.4%
Projections
FY23 FY24 FY25 FY26
130,147
90%
117,133
4.50
2,234,544
Terminal
1,344,040
5,628,948
Appendix
No
no no
91,883
SD/USD): 1
re the same period)
no
1